Skip to main content

For Healthcare Professionals

Patient Experience

Patient Experience

TREATMENT PATHWAY

GENE THERAPY WITH LENMELDY1

Patients should be evaluated to confirm their diagnosis and initiate the process of creating and administering LENMELDY

Hear how one father feels about his experience with LENMELDY

LENMELDY: Transforming the Lives of a Family

Listen to one father share his personal experience with LENMELDY. From getting the MLD diagnosis, to his thoughts and feelings on life before and after treatment, this father tells his story to help other families with an MLD diagnosis.
MLD CHANGED EVERYTHING
MLD CHANGED EVERYTHING

Next, hear why this family chose gene therapy by clicking the Next Video button below.

Next, hear why this family chose gene therapy by clicking the Next Video button or the video icon on the right.

LEARNING ABOUT GENE THERAPY
LEARNING ABOUT GENE THERAPY

Next, hear this father describe the gene therapy process by clicking the Next Video button below.

Next, hear this father describe the gene therapy process by clicking the Next Video button or the video icon on the right.

THE GENE THERAPY PROCESS
THE GENE THERAPY PROCESS

Next, hear this father talk about his daughter’s treatment results by clicking the Next Video button below.

Next, hear this father talk about his daughter’s treatment results by clicking the Next Video button or the video icon on the right.

GENE THERAPY RESULTS AND FOLLOW-UP
GENE THERAPY RESULTS AND FOLLOW-UP

Next, hear this father describe life after gene therapy with LENMELDY by clicking the Next Video button below.

Next, hear this father describe life after gene therapy with LENMELDY by clicking the Next Video button or the video icon on the right.

OUR LIFE AFTER GENE THERAPY
OUR LIFE AFTER GENE THERAPY

Next, hear what this father has to share with other families living with MLD by clicking the Next Video button below.

Next, hear what this father has to share with other families living with MLD by clicking the Next Video button or the video icon on the right.

FOR FAMILIES LIVING WITH MLD
FOR FAMILIES LIVING WITH MLD

Next, learn more about how LENMELDY may be able to help.

MLD CHANGED EVERYTHING
MLD CHANGED EVERYTHING
LEARNING ABOUT GENE THERAPY
LEARNING ABOUT GENE THERAPY
THE GENE THERAPY PROCESS
THE GENE THERAPY PROCESS
GENE THERAPY RESULTS AND FOLLOW-UP
GENE THERAPY RESULTS AND FOLLOW-UP
OUR LIFE AFTER GENE THERAPY
OUR LIFE AFTER GENE THERAPY
FOR FAMILIES LIVING WITH MLD
FOR FAMILIES LIVING WITH MLD
previous arrow
next arrow
Shadow

Patient Support Program

ORCHARD ASSIST

Helping your patients with gene therapy

Orchard Assist is here to help patients and their families who have received an MLD diagnosis and want to pursue gene therapy from Orchard Therapeutics. If you or your patients have questions about insurance coverage, reimbursement, or billing, Orchard Assist is here to help.

Orchard Assist can help you access information related to your patients’ coverage and help your patients’ caregivers find support, access resources, and connect with a QTC. A representative from Orchard Assist can provide information regarding:

  • Information on benefits investigation and prior authorization
  • Payer medical policies
  • Reimbursement and billing
Contact your Advanced Therapeutic Account Manager to discuss how Orchard Assist can help your patients:

Email MLDinformation@orchard-tx.com or visit OrchardAssist.com

HSC, hematopoietic stem cell; LVV, lentiviral vector; MLD, metachromatic leukodystrophy.

Reference: 1. LENMELDY (atidarsagene autotemcel) Prescribing Information. Orchard Therapeutics.

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

• Thrombosis and Thromboembolic Events:

Treatment with LENMELDY may increase the risk of thrombosis and thromboembolic events.

INDICATION

LENMELDY™ (atidarsagene autotemcel) is an autologous hematopoietic stem cell-based gene therapy indicated for the treatment of children with pre-symptomatic late infantile (PSLI), pre-symptomatic early juvenile (PSEJ), or early symptomatic early juvenile (ESEJ) metachromatic leukodystrophy (MLD).

+